Paul Bollyky

Publications

• Evaluation of in vivo T cell kinetics: use of heavy isotope labelling in type 1 diabetes. Bollyky JB, Long SA, Fitch M, Bollyky PL, Rieck M, Rogers R, Samuels PL, Sanda S, Buckner JH, Hellerstein MK, Greenbaum CJ. Clin Exp Immunol. 2013; 172 (3): 363-74
• Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Evanko SP, Potter-Perigo S, Bollyky PL, Nepom GT, Wight TN. Matrix Biol. 2012; 31 (2): 90-100
• Reversal of diabetes in mice with a bioengineered islet implant incorporating a type I collagen hydrogel and sustained release of vascular endothelial growth factor. Vernon RB, Preisinger A, Gooden MD, D'Amico LA, Yue BB, Bollyky PL, Kuhr CS, Hefty TR, Nepom GT, Gebe JA. Cell Transplant. 2012; 21 (10): 2099-110
• Science and government. Obama and the promotion of international science. Bollyky TJ, Bollyky PL. Science. 2012; 338 (6107): 610-2
• The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Bollyky PL, Bogdani M, Bollyky JB, Hull RL, Wight TN. Curr Diab Rep. 2012; 12 (5): 471-80
• ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Bollyky PL, Wu RP, Falk BA, Lord JD, Long SA, Preisinger A, Teng B, Holt GE, Standifer NE, Braun KR, Xie CF, Samuels PL, Vernon RB, Gebe JA, Wight TN, Nepom GT. Proc Natl Acad Sci U S A. 2011; 108 (19): 7938-43
• Isolated infection of a decommissioned penile prosthesis reservoir with Actinomyces neuii. Hsi RS, Hotaling JM, Spencer ES, Bollyky PL, Walsh TJ. J Sex Med. 2011; 8 (3): 923-6
• Low-dose antigen promotes induction of FOXP3 in human CD4+ T cells. Long SA, Rieck M, Tatum M, Bollyky PL, Wu RP, Muller I, Ho JC, Shilling HG, Buckner JH. J Immunol. 2011; 187 (7): 3511-20
• Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus. Ge X, Tan V, Bollyky PL, Standifer NE, James EA, Kwok WW. J Virol. 2010; 84 (7): 3312-9
• Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH. Diabetes. 2010; 59 (2): 407-15
• Peptide-MHC cellular microarray with innovative data analysis system for simultaneously detecting multiple CD4 T-cell responses. Ge X, Gebe JA, Bollyky PL, James EA, Yang J, Stern LJ, Kwok WW. PLoS One. 2010; 5 (6): e11355
• Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse. Bollyky PL, Evanko SP, Wu RP, Potter-Perigo S, Long SA, Kinsella B, Reijonen H, Guebtner K, Teng B, Chan CK, Braun KR, Gebe JA, Nepom GT, Wight TN. Cell Mol Immunol. 2010; 7 (3): 211-20
• CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP, Evanko SP, Buckner JH, Wight TN, Nepom GT. J Immunol. 2009; 183 (4): 2232-41
• Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. Bollyky PL, Falk BA, Wu RP, Buckner JH, Wight TN, Nepom GT. J Leukoc Biol. 2009; 86 (3): 567-72
• The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, Gersuk VH, Aderem A, Hawn TR, Nepom GT. PLoS One. 2009; 4 (4): e5063
• Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. Bollyky PL, Lord JD, Masewicz SA, Evanko SP, Buckner JH, Wight TN, Nepom GT. J Immunol. 2007; 179 (2): 744-7
• Histoplasmosis presenting as an isolated spinal cord lesion. Bollyky PL, Czartoski TJ, Limaye A. Arch Neurol. 2006; 63 (12): 1802-3
• CD1d-restricted T-cell subsets and dendritic cell function in autoimmunity. Bollyky PL, Wilson SB. Immunol Cell Biol. 2004; 82 (3): 307-14
• Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. Wilson SB, Kent SC, Horton HF, Hill AA, Bollyky PL, Hafler DA, Strominger JL, Byrne MC. Proc Natl Acad Sci U S A. 2000; 97 (13): 7411-6
• Reconstructing the complex evolutionary history of hepatitis B virus. Bollyky PL, Holmes EC. J Mol Evol. 1999; 49 (1): 130-41
• Recombination between sequences of hepatitis B virus from different genotypes. Bollyky PL, Rambaut A, Harvey PH, Holmes EC. J Mol Evol. 1996; 42 (2): 97-102